Hamilton Thorne Ltd. (CVE:HTL – Get Free Report)’s stock price traded up 4.3% during trading on Monday . The stock traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares traded hands during mid-day trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Stock Performance
The company’s 50-day simple moving average is C$1.45 and its 200 day simple moving average is C$1.45. The stock has a market cap of C$149.69 million, a P/E ratio of 58.94 and a beta of 0.54. The company has a current ratio of 2.04, a quick ratio of 2.25 and a debt-to-equity ratio of 43.24.
About Hamilton Thorne
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Further Reading
- Five stocks we like better than Hamilton Thorne
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
